If you suffered permanent vision loss after taking Ozempic, Wegovy, or another GLP-1 medication, you may have grounds to file a pharmaceutical injury lawsuit. A new FDA warning has raised serious questions about whether drug manufacturers adequately disclosed the potential risk of a rare eye condition that can cause blindness. On November 9, 2026, the... Continue Reading
Stories are matched on the docket number and on GLP-1, Mounjaro, Ozempic, Wegovy, Zepbound, semaglutide and related names, with a litigation word in the same story for product names.